One would figure either a misleading statement or $6m is more than is needed, in order to minimise share dilution.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025